Warda Qamar

Dr. Warda Qamar


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 May 2022 in Life
Verified
Journal Article
Open access
PDF file
MAMughees Aizaz Alvi
Mughees Aizaz Alvi
SKSadiq Khan
Sadiq Khan
RARana Muhammad Athar Ali
Rana Muhammad Athar Ali
WQWarda Qamar
Warda Qamar
MSMuhammad Saqib
Muhammad Saqib
WJWan-Zhong Jia
Wan-Zhong Jia
Echinococcosis is a serious public health issue that affects people and livestock all over the world. Many synthetic and natural products have been examined in vitro and in vivo on Echinococcus species but only a few are used clinically, however, they may cause some complications and side effects. To overcome these limitations, new horizons of herbal drugs to cure echinococcosis are opening with every passing day. To summarize the developments during the last 21 years, we conducted this review of the literature to identify medicinal herbs utilized throughout the world that have anti-Echinococcus activity. From 2000 to 2021, data were carefully obtained from four English databases: Science Direct, PubMed, Scopus, and OpenGrey. Botanical name, extraction technique, extract quantities, efficacy, duration of treatment, year of publication, and half-maximal inhibitory concentration (IC50) values were all well noted. Ninety-one published papers, with 78 in vitro and 15 in vivo, fulfilled our selection criteria. Fifty-eight different plant species were thoroughly tested against Echinococcus granulosus. Zataria multiflora, Nigella sativa, Berberis vulgaris, Zingiber officinale (ginger), and Allium sativum were the most often utilized anti-Echinococcus herbs and the leaves of the herbs were extensively used. The pooled value of IC50 was 61 (95% CI 60–61.9) according to the random effect model and a large degree of diversity among studies was observed. The current systematic study described the medicinal plants with anti-Echinococcus activity, which could be investigated in future experimental and clinical studies to identify their in vivo efficacy, lethal effects, and mechanisms of action.

4 March 2024 in Biological Trace Element Research
Verified
Journal Article
Closed access
PDF file
SMSahar Mustafa
Sahar Mustafa
LALafi M. Alharbi
Lafi M. Alharbi
MAMona Z. Abdelraheem
Mona Z. Abdelraheem
MMMuhammad Mobashar
Muhammad Mobashar
WQWarda Qamar
Warda Qamar
RARao Zahid Abbas
Rao Zahid Abbas

29 October 2020 in Pathogens
Verified
Journal Article
Open access
PDF file
MAMughees Aizaz Alvi
Mughees Aizaz Alvi
JOJohn Ohiolei
John Ohiolei
LLLi Li
Li Li
MSMuhammad Saqib
Muhammad Saqib
Muhammad Hammad HussainMuhammad Hammad Hussain
Muhammad Hammad Hussain
WJWan-Zhong Jia
Wan-Zhong Jia
Cystic echinococcosis (CE) is a World Health Organization (WHO)-listed neglected tropical farm economy jeopardizing and public health concern disease. This study was aimed at furnishing sero-epidemiological baseline data of CE in sheep in Pakistan, where data are non-existent. For this purpose, two sheep-rich provinces of Pakistan were selected, and 728 sheep sera were collected using probability proportional to size (PPS) statistical technique. Epidemiological information was recorded on a questionnaire for the estimation of potential risk factors. The serum samples were analyzed for IgG antibodies against Echinococcus granulosus using an in-house-developed EgAgB-based ELISA kit. The overall seroprevalence recorded was 21.98% (160/728) in the tested sheep, suggesting higher seropositivity in sheep from Punjab (23.73%) as compared to Khyber Pakhtunkhwa (KPK) (19.04%). The overall apparent prevalence observed by this ELISA method was almost similar to the calculated true prevalence (21.77%). Prevalence was significantly different (p < 0.05) among sheep from different districts. Higher prevalence was found in females (22.54%, OR 1.41), age group > 5 years (29.66%, OR 1.64), crossbreeds (42.85%, OR 2.70), and sheep with pasture access (25.96%, OR 3.06). Being in age group > 5 years and having pasture access were the factors significantly associated with seropositivity (p < 0.05). This study provides serological evidence of E. granulosus infection in sheep and can be used as a model for ante-mortem screening of the sheep globally.

1 January 2024 in Journal of Advanced Veterinary and Animal Research
Verified
Journal Article
Open access
AAAyed Alshammari
Ayed Alshammari
MSMuhammad Subhani
Muhammad Subhani
Majed H. WakidMajed H. Wakid
Majed H. Wakid
AAAbdulsalam A M Alkhaldi
Abdulsalam A M Alkhaldi
SHShujaat Hussain
Shujaat Hussain
MAMughees Aizaz Alvi
Mughees Aizaz Alvi
Objectives: Alveolar echinococcosis is caused by Echinococcus multilocularis, a parasite of zoo¬notic significance with a wide range of intermediate and final hosts, and the parasite survives suc¬cessfully in diversified conditions. Plentiful studies have been done to study the genetic structure of the population of the parasite and the level of intimate kinship using mitochondrial (mt) DNA. The present study was conducted to investigate the population structure, genetic variation, and phylogenetic relationship of various isolates of E. multiocularis submitted to GenBank worldwide. Sequences of mt genes (mt-cytochrome c oxidase (cox1), mt-NADH dehydrogenase (nad1)) of E. multilocularis were analyzed to achieve the set goals. Materials and Methods: A total of 275 and 124 gene sequences of mt-cox1 and mt-nad1 belong¬ing to E. multilocularis, respectively, were retrieved from the National Center for Biotechnology Information GenBank. The retrieved sequences were subjected to alignment with respective reference sequences using MEGA software. The PopArt software was used to establish medi¬an-joining networks, while DnaSp was used to calculate neutrality and diversity indices. MrBayes software was used to investigate the phylogenetic association between haplotypes based on Bayesian phylogeny. Results: Approximately 13 and 20 distinctive haplotypes of nad1 and cox1 genes, respectively, were observed in the present study. In both of the mt genes, diversity indices indicated low haplo¬type (mt-cox1 = 0.140; mt-nad1 = 0.374) and nucleotide (mt-cox1 = 0.00111; mt-nad1 = 0.00287) diversities. The values of Tajima’s D and Fu Fs for a population of both of the genes under study were found to be negative. Conclusion: This study is a maiden attempt to provide insights into the population structure and genetic variation of E. multilocularis on a global scale. However, it is suggested that to better understand the population structure and genetic diversity of E. multilocularis, more geographical locations and amplifications of full-length gene sequences should be considered, which could be helpful in widening the insights into the genetic diversity of E. multilocularis.

11 December 2023 in Parasite Epidemiology and Control
Verified
Journal Article
Open access
AAAyed Alshammari
Ayed Alshammari
UAUmair Ali
Umair Ali
AKAbdulbaset Mohammed Kabli
Abdulbaset Mohammed Kabli
Majed H. WakidMajed H. Wakid
Majed H. Wakid
MSMuhammad Saqib
Muhammad Saqib
MAMughees Aizaz Alvi
Mughees Aizaz Alvi
Monieziasis is a parasite-borne production-limiting disease of livestock. Moniezia expansa is the most important species having cosmopolitan distribution. Despite of numerous prevalence reports, very little information is available about the evolutionary biology and population genetics of M. expansa. To close this research gap, this study was undertaken to recognize and inspect the genetic variation of M. expansa populations around the world using the cox1 and nad1 genes and deduce phylogenetic relationships with M. expansa populations. The cox1 and nad1 gene sequences were downloaded from the NCBI GenBank database. Followed by sequence alignment, median-joining networks were constructed using PopArt software. Diversity and neutrality indices were computed through DnaSp software while MEGA software was used to draw the maximum-likelihood phylogenetic tree. Thirty-two cox1 sequences, from five different countries, and 9 nad1 sequences from three different countries, were among the sequences used in this study. The cox1 and nad1 gene sequences had mutations in 97 and 36 different places, respectively. Twenty and 7 unique haplotypes were discovered for the cox1 and nad1 gene sequences, respectively. Comparable haplotype diversities were observed for both the genes under study (cox1 = 0.950; nad1 = 0.944). Negative Tajima's D and Fu Fs were found for the cox1 gene while these indices were positive for the nad1 gene. Phylogenetic analysis also showed the existence of unique haplotypes for both the cox1 and nad1 genes. The results of this study indicate that there is the existence of a huge genetic diversity in M. expansa isolates. For future studies, it is recommended that longer gene sequences should be used to describe genetic variation among M. expansa isolates as the length of the gene under study affects the genetic variation. Moreover, additional mitochondrial markers should also be investigated because the assertive strength of a group of gene targets is superior to defining genetic diversity.

1 April 2024 in Annals of Animal Science
Verified
Journal Article
Open access
PDF file
STSaleha Tahir
Saleha Tahir
RARao Zahid Abbas
Rao Zahid Abbas
WQWarda Qamar
Warda Qamar
MAMuhammad Imran Arshad
Muhammad Imran Arshad
MAMughees Aizaz Alvi
Mughees Aizaz Alvi
TZTean Zaheer
Tean Zaheer
Worldwide, microbial infections have a serious impact because they cause infectious diseases, death, and significant economic losses. Zoonosis is now a major public health issue on a global scale because of the fast expansion of human exploitation of nature and animal husbandry. Notably, in the past 30 years, over 30 novel human infections have been discovered, 75% of which fall under the category of zoonosis. Resistant strains have emerged as a result of improper use of antibiotics and insufficient infection management posing a serious risk to both public health and the global economy. As alternatives, antimicrobial peptides are showing good results. The majority of living things use antibacterial peptides (ABPs) as a key part of their natural defenses against invading infections. These peptides are cationic, amphipathic, and relatively tiny with varied sequences, structures, and lengths. For the delivery of these efficacious biological peptides, nanoparticles are providing opportunities for effective, safe, and viable delivery. An innovative method of treating infectious diseases is demonstrated by nanoparticles and antibacterial peptides. When ABPs are combined with carrier nanoparticles to optimize distribution, their half-life may be increased, allowing for lower dosages and ultimately lower toxicity. For biological applications, ABPs and nanoparticle conjugates have become effective methods, enabling the treatment, prevention of disease, and detection. More than 50 peptide medications have been made available for purchase on the market as of 2018. Around 25 billion USD is spent on peptide medications each year, including ABPs. But still, there is a gap in the distribution of these ABPs as an alternative to synthetic antibiotics. It might be due to the high cost of these goods. Thus, scientists, researchers, and commercializing companies should work together so that these ABPs with a safe delivery system should be available in the market to combat resistant strains of bacteria. In doing so, we draw attention to the significant advancements made in the field as well as the difficulties still encountered in developing imaging species, active therapies, and nano-drug delivery systems that are functionalized with peptides and proteins for clinical use.